Search hospitals > Arizona > Gilbert
Banner MD Anderson Cancer Center
Claim this profileGilbert, Arizona 85234
Global Leader in Cancer
Global Leader in Lymphoma
Conducts research for Tumors
Conducts research for Breast Cancer
Conducts research for Non-Small Cell Lung Cancer
222 reported clinical trials
25 medical researchers
Summary
Banner MD Anderson Cancer Center is a medical facility located in Gilbert, Arizona. This center is recognized for care of Cancer, Lymphoma, Tumors, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Banner MD Anderson Cancer Center is involved with conducting 222 clinical trials across 246 conditions. There are 25 research doctors associated with this hospital, such as Rajneesh Nath, MD, Jiaxin Niu, MD, Shakeela Bahadur, and Lida Mina.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Lymphoma
Global LeaderCD19 positive
CD5 positive
Philadelphia chromosome positive
Top PIs
Rajneesh Nath, MDBanner MD Anderson Cancer Center6 years of reported clinical research
Studies Leukemia
Studies Lymphoma
12 reported clinical trials
23 drugs studied
Jiaxin Niu, MDBanner MD Anderson Cancer Center6 years of reported clinical research
Studies Non-Small Cell Lung Cancer
Studies Cancer
10 reported clinical trials
17 drugs studied
Shakeela BahadurBanner MD Anderson Cancer Center5 years of reported clinical research
Expert in Breast Cancer
Studies Cancer
11 reported clinical trials
29 drugs studied
Lida MinaBanner MD Anderson Cancer Center1 year of reported clinical research
Studies Breast Cancer
Studies Endometrial Cancer
8 reported clinical trials
18 drugs studied
Clinical Trials running at Banner MD Anderson Cancer Center
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
B-Cell Lymphoma
Tumors
Squamous Cell Carcinoma
Non-Hodgkin's Lymphoma
Lymphoma
Bladder Cancer
Inavolisib + Fulvestrant vs Alpelisib + Fulvestrant
for Breast Cancer
This is a Phase III, multicenter, randomized, open-label, global study designed to evaluate the efficacy and safety of inavolisib plus fulvestrant compared with alpelisib plus fulvestrant in patients with hormone receptor (HR)-positive, human epidermal growth factor receptor 2 (HER2) -negative, PIK3CA-mutated, locally advanced (LA) or metastatic breast cancer (mBC), who progressed during or after cyclin dependent kinase 4/6i (CDK4/6i)-based therapy.
Recruiting2 awards Phase 310 criteria
Imlunestrant + Abemaciclib
for Breast Cancer
This study is evaluating whether a drug called LY3484356 can help treat breast cancer.
Recruiting2 awards Phase 39 criteria
Imlunestrant
for Early Breast Cancer
The main purpose of this study is to measure how well imlunestrant works compared to standard hormone therapy in participants with early breast cancer that is estrogen receptor positive (ER+) and human epidermal receptor 2 negative (HER2-). Participants must have already taken endocrine therapy for two to five years and must have a higher-than-average risk for their cancer to return. Study participation could last up to 10 years.
Recruiting2 awards Phase 36 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Banner MD Anderson Cancer Center?
Banner MD Anderson Cancer Center is a medical facility located in Gilbert, Arizona. This center is recognized for care of Cancer, Lymphoma, Tumors, Breast Cancer, Non-Small Cell Lung Cancer and other specialties. Banner MD Anderson Cancer Center is involved with conducting 222 clinical trials across 246 conditions. There are 25 research doctors associated with this hospital, such as Rajneesh Nath, MD, Jiaxin Niu, MD, Shakeela Bahadur, and Lida Mina.